AstraZeneca says its COVID-19 vaccine was extensively tested for safety as Denmark’s health authority says there is no evidence of a connection between the vaccine and blood clots

The Danish Health Authority, the European Medicines Agency and health authorities in Canada have all stated there is no evidence that AstraZeneca’s COVID-19 vaccine was responsible for blood clots that developed in some people who had received the shot.

At least nine European countries have temporarily suspended the use of the AstraZeneca vaccine.

Following news of the suspension, a spokesperson for AstraZeneca said “the safety of the vaccine has been extensively studied in Phase III clinical trials and Peer-reviewed data confirms the vaccine is generally well tolerated.”